Answers are grounded in this paper and cite their sources.
The weight-reducing property of molindone, a recently introduced antipsychotic drug, was tested in 9 hospitalized chronic schizophrenic patients. There was an average weight loss of 7.6 kg after 3 months on molindone; most of the loss occurred during the first month. The mechanism producing this weight loss is uncertain, but a central anorexigenic effect may be an important factor.
No takes yet. Share an insight, caveat, or question.
Gárdos et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: